At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

The pharmaceutical manufacturing sector is experiencing a profound transformation driven by technological advancements, regulatory shifts, and market dynamics. Industry leaders are facing both ...

Furthermore, personalized medicine and the increase in pharmaceutical alliances are likely to propel the oral solid dose contract manufacturing market, offering more opportunities for industry ...

India is keen to expand its manufacturing sector, with a focus on diversifying into newer lines of production, advancing the industrial capacity of traditional sectors like automobiles, and ...

The Trump administration has pushed corporations to open more facilities in the U.S., emphasizing its “America first” policies that seek to discourage imports and increase manufacturing employment.

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Production costs reflect all of the expenses associated with a company conducting its business while manufacturing costs represent only the expenses necessary to make the product. Both of these ...

Issues such as environmental impacts caused by, for example, single-use plastics in pharmaceutical packaging and manufacturing have been highlighted as potential areas of concern, with 70% of ...

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications.